ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01617967
Brief Title: Safety and Tolerability of Patisiran (ALN-TTR02) in Transthyretin (TTR) Amyloidosis

First Submitted : June 7, 2012
First Submitted that Met QC Criteria : June 11, 2012
First Posted : June 13, 2012 (Estimate)

Results First Submitted : August 30, 2018
Results First Submitted that Met QC Criteria : October 23, 2018
Results First Posted : November 21, 2018

Certification/Extension First Submitted : June 2, 2017
Certification/Extension First Submitted that Met QC Criteria : July 13, 2017
Certification/Extension First Posted : July 17, 2017

Last Update Submitted that Met QC Criteria : October 23, 2018
Last Update Posted : November 21, 2018